|
|
|
|
|
 |
News and Press Releases |
 |
Bormioli Pharma runs Envision 2020: A Digital Event to Showcase The New Strategic Directions, Brand-New Product Portfolios and Prototypes
Parma, 24 November 2020 – Bormioli Pharma will showcase its
brand-new product portfolios, products and prototypes during “Bormioli
Pharma Envision 2020”, a digital event that will take place in the first
half of December open to all the stakeholders.
The
event will be the occasion to get in touch with the leading European
pharma packaging manufacturer in glass and plastic in such hectic times
for the industry. Even during the Covid-19 pandemic, the company has
kept the momentum for its expansion and growth process, finalizing new
investments and M&As to enlarge its industrial platform and the
products range.
More info >> |
|
 |
White Papers |
 |
|
The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing
GE Healthcare Life Sciences
For the past several years, the biopharma industry has been buffeted by
dynamic market conditions that are rapidly reshaping manufacturing
requirements. These factors include:
• The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model
• Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint
• The emergence of biosimilars and continued evolution of healthcare
reform, which will increasingly pressure drug pricing and require
greater cost discipline
• Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures
• Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >> |
|
|
.jpg)
